홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
HRMY
#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.540
0
+0.25%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+0.25%
월간 변동
-24.24%
6달 변화
-7.64%
년간 변동율
-7.64%
이전 종가
28.470
0
Open
28.540
0
Bid
Ask
Low
28.540
0
High
28.540
0
양
110
마켓
주식
헬스케어
HRMY
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
56.89 M
58.87 M
59.62 M
56.77 M
57.35 M
57.84 M
—
Valuation ratios
Enterprise value
1.83 B
2.28 B
2.91 B
1.44 B
1.52 B
1.41 B
5.04 B
Price to earnings ratio
14.58
73.52
17.83
14.46
13.71
13.81
45.34
Price to sales ratio
5.83
8.27
7.39
3.19
2.79
2.52
9.44
Price to cash flow ratio
-312.12
25.61
22.4
8.47
9.06
6.29
27.43
Price to book ratio
9.59
13.54
8.03
3.98
3.02
2.52
4.49
Enterprise value to EBITDA ratio
61.68
20.96
20.12
6.62
7.12
6.1
20.5
Profitability ratios
Return on assets %
0.09
0.08
0.27
0.16
0.15
0.12
0.14
Return on equity %
0.38
0.19
0.45
0.28
0.22
0.18
0.2
Return on invested capital %
25.57
193.23
56.92
157.94
129.43
141.66
124.81
Gross margin %
82.64
81.82
80.93
79.17
78.06
77.16
310.62
Operating margin %
10.63
28.66
27.45
32.99
26.7
24
97.64
EBITDA margin %
18.55
35.56
33.07
37.27
29.85
26.65
115.7
Net margin %
23.13
11.33
41.44
22.14
20.36
18.27
74.97
Liquidity ratios
Quick ratio
1.93
5.21
5.02
2.72
3.27
3.58
14.74
Current ratio
1.95
5.29
5.07
2.75
3.31
3.6
14.86
Inventory turnover
7.26
13.45
19.13
25.1
24.97
31.6
31.21
Asset turnover
0.37
0.71
0.79
0.78
0.79
0.76
0.77
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.45
0.44
0.28
0.22
0.16
0.11
0.52
Long term debt to total equity ratio
2
1.02
0.47
0.38
0.25
0.17
0.76
Per share metrics
Operating cash flow per share
0.12
1.66
2.36
3.63
3.8
5.95
5.95
EBIT per share
0.66
1.48
1.97
3.18
3.3
3.56
3.56
EBITDA per share
1.15
1.83
2.37
3.59
3.69
3.95
4.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
8.87
3.96
5.29
5.85
8.07
13.24
43.04
Net current asset value per share
10.2
4.8
6.55
7.47
10.01
15.49
52.59
Tangible book value per share
-2.53
0.72
3.96
5.46
9.43
13.34
47.91
Working capital per share
4.98
3.9
5.26
4.76
6.98
11.19
38.41
Book value per share
3.77
3.15
6.59
7.74
11.39
14.86
54.63
뉴스
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
하모니 바이오사이언스, Wakix 제네릭 조기 출시로 목표 주가 하향
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
트루이스트, 하모니 바이오사이언스에 ’보유’ 등급 재확인, 목표가 25달러 제시
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target
AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales
BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market